Kennicott Capital Management’s Medtronic MDT Stock Holding History

Kennicott Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,298	Closed	-$944K	–	44
2023 Q4	$944K	Hold	3,298	–	–	0.46%	23
2023 Q3	$891K	Sell	3,298 -6,596	-67%	-$552K	0.51%	24
2023 Q2	$924K	Buy	9,894 +6,596	+200%	+$568K	0.47%	24
2023 Q1	$901K	Buy	3,298 +349	+12%	+$28.4K	0.56%	23
2022 Q4	$837K	Hold	2,949	–	–	0.64%	23
2022 Q3	$746K	Hold	2,949	–	–	0.6%	25
2022 Q2	$793K	Hold	2,949	–	–	0.61%	24
2022 Q1	$852K	Hold	2,949	–	–	0.49%	25
2021 Q4	$886K	Hold	2,949	–	–	0.53%	27
2021 Q3	$814K	Hold	2,949	–	–	0.59%	29
2021 Q2	$805K	Buy	+2,949	New	+$370K	0.6%	29

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kennicott Capital Management's MDT Position: Q1 2024 in Review

Kennicott Capital Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 3,298 shares — an estimated $944K sold.

Kennicott Capital Management first reported a position in MDT in Q2 2021 and held it in 11 quarters. The position peaked at $944K in Q4 2023. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

Kennicott Capital Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
Kennicott Capital Management sold 3,298 Medtronic shares in Q1 2024, an estimated $944K.
Kennicott Capital Management first reported a position in Medtronic in Q2 2021 and held it in 11 quarters.
Kennicott Capital Management's Medtronic position peaked at $944K in Q4 2023.
2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Kennicott Capital Management's 13F filing for Q1 2024, filed 25 Apr 2024.